Bio-Techne Dividends and Buybacks
Dividend criteria checks 0/6
Bio-Techne is a dividend paying company with a current yield of 0.5%.
Key information
0.5%
Dividend yield
2.4%
Buyback Yield
| Total Shareholder Yield | 2.9% |
| Future Dividend Yield | 0.5% |
| Dividend Growth | 0.03% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 64% |
Recent dividend and buyback updates
Recent updates
Bio-Techne Corporation (NASDAQ:TECH) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Nov 08
Bio-Techne: Coveted Life Sciences Asset On Sale Due To Academic Pressures
Aug 05Investors Still Waiting For A Pull Back In Bio-Techne Corporation (NASDAQ:TECH)
Jul 28What Does Bio-Techne Corporation's (NASDAQ:TECH) Share Price Indicate?
May 29Is Bio-Techne (NASDAQ:TECH) Using Too Much Debt?
Apr 28Market Participants Recognise Bio-Techne Corporation's (NASDAQ:TECH) Earnings
Apr 07Bio-Techne: Attractive Markets And A Good Moat, But Valuation Is Seldom A Bargain
Feb 27Here's Why Bio-Techne (NASDAQ:TECH) Can Manage Its Debt Responsibly
Jan 21At US$71.48, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
Jan 03Why We're Not Concerned About Bio-Techne Corporation's (NASDAQ:TECH) Share Price
Dec 15
Innovations In Molecular Diagnostics And Decisive Focus On Growth Verticals Promise Revenue Surge Amid Challenges
Bio-Techne's investment in advanced diagnostics and specialized instruments like Leo suggests strong potential for revenue growth from increased sales and market adoption.Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Apr 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: TECH is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: TECH is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Bio-Techne Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (TECH) | 0.5% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.4% |
| Industry Average (Life Sciences) | 0.5% |
| Analyst forecast (TECH) (up to 3 years) | 0.5% |
Notable Dividend: TECH's dividend (0.5%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.47%).
High Dividend: TECH's dividend (0.5%) is low compared to the top 25% of dividend payers in the US market (4.48%).
Earnings Payout to Shareholders
Earnings Coverage: TECH is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: TECH is not paying a notable dividend for the US market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/04 20:21 |
| End of Day Share Price | 2025/12/03 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bio-Techne Corporation is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Catherine Ramsey Schulte | Baird |
| Robert Wasserman | Benchmark Company |